Form 8-K - Current report:
SEC Accession No. 0001477932-25-001737
Filing Date
2025-03-14
Accepted
2025-03-14 16:35:16
Documents
15
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K celz_8k.htm   iXBRL 8-K 24342
  Complete submission text file 0001477932-25-001737.txt   144597

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA celz-20250310.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20250310_lab.xml EX-101.LAB 14114
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20250310_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20250310_pre.xml EX-101.PRE 8907
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20250310_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT celz_8k_htm.xml XML 3789
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41120 | Film No.: 25740790
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)